Overview

• ANMAT testing confirmed Klebsiella pneumoniae and Ralstonia pickettii contamination in patients and in ampoules from two HLB Pharma batches.
• Officials estimate more than 300,000 ampoules may have been affected and about 45,000 were administered before the recalled batches were withdrawn.
• Federal Judge Ernesto Kreplak’s investigation has identified 24 suspects connected to HLB Pharma and Laboratorio Ramallo who now face asset freezes and travel bans.
• President Javier Milei’s administration has accused the manufacturer of criminal misconduct and cited failures in drug distribution controls that delayed detection.
• Investigators warn the death toll could rise further as they review additional medical records from hospitals across several provinces.